About Rare Disease Day
Rare Disease Day traditionally takes place on the last day of February each year, with the next one falling on February 29, 2020 – a rare occasion. Rare Disease Day is honored around the world with the objective to raise awareness amongst the general public and decision makers regarding rare diseases and the challenges patients face.
Rare diseases collectively affect not just a few, but over 350 million people around the world, which is equivalent to 4% of the world population – thus not as rare as the term suggests.
About Rare Disease Day at CENTOGENE
Every year throughout February, CENTOGENE takes the opportunity to enhance the visibility of rare diseases. Rare Disease Day is a special opportunity to bring together individuals to raise awareness and advocate for faster diagnosis and easier access to innovative treatments for all those affected by rare diseases.
CENTOGENE’s Rare Disease Day 2020 (www.RDD2020.eu) campaign enforces the overall goal – to raise awareness amongst policy makers, public authorities, researchers, health professionals, and the general public. This year’s Rare Disease Day specifically focuses on the need to find solutions for shortening patients’ diagnostic odyssey.
With events being held in Lahore/Pakistan, Berlin, and Mexico City, we underline our commitment in supporting patients, patient organizations, and local physicians around the world.
We look forward to being part of the global community on RDD2020 and shining a spotlight on rare diseases – increasing public knowledge, while encouraging researchers and decision makers to address the needs of those living with rare diseases.
CENTOGENE engages in diagnosis and research around rare diseases transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. Our goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our extensive rare disease knowledge, including epidemiological and clinical data and innovative biomarkers. CENTOGENE has developed a global proprietary rare disease platform based on our real-world data repository with approximately 2.1 billion weighted data points from approximately 500,000 patients representing over 120 different countries as of December 31, 2019, or an average of approximately 600 data points per patient.
The Company’s platform includes epidemiologic, phenotypic, and genetic data that reflects a global population, and also a biobank of these patients’ blood samples. CENTOGENE believes this represents the only platform that comprehensively analyzes multi-level data to improve the understanding of rare hereditary diseases, which can aid in the identification of patients and improve our pharmaceutical partners’ ability to develop orphan drugs. As of December 31, 2019, the Company collaborated with over 35 pharmaceutical partners for over 40 different rare diseases.
Frequently Asked Questions
How can I attend CENTOGENE’s RDD2020 as press?
Please email press(at)centogene(dot)com for more information about press accreditation.
How can I request an interview with someone at CENTOGENE’s RDD2020?
Please email press(at)centogene(dot)com with the the subject line, “Interview Request.”